Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal In
The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.
| Condition(s) | Infectious Diseases of Spine |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs. |
| Who can participate | Inclusion Criteria: * Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy. Exclusion Criteria: * Pregnant/lactating women. * There are other factors that the researchers think are not suitable for inclusion |
| Sex | All |
| Lead sponsor | Shandong University |
| Locations | Jinan, China |
| Start date | 2024-10-12 |
| NCT ID | NCT06711575 |
| Official listing | https://clinicaltrials.gov/study/NCT06711575 |